BRAF-MT CRC has more stromal cells, more immune cell infiltration, and lower tumor purity in a recent study that evaluated the immune microenvironment of BRAF-MT CRC using The Cancer Genome Atlas and Gene Expression Omnibus data. Here, BRAF is linked to colorectal carcinoma.